Cargando…
Malaria treatment policies and drug efficacy in Haiti from 1955-2012
OBJECTIVES: Chloroquine (CQ), after 67 years of use in Haiti, is still part of the official treatment policy for malaria. Several countries around the world have used CQ in the past due to its low incidence of adverse events, therapeutic efficacy, and affordability, but were forced to switch treatme...
Autores principales: | von Fricken, Michael E, Weppelmann, Thomas A, Hosford, Jennifer D, Existe, Alexander, Okech, Bernard A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366907/ https://www.ncbi.nlm.nih.gov/pubmed/25848539 http://dx.doi.org/10.1186/2052-3211-6-10 |
Ejemplares similares
-
High frequency of the erythroid silent Duffy antigen genotype and lack of Plasmodium vivax infections in Haiti
por: Weppelmann, Thomas A, et al.
Publicado: (2013) -
Age-specific malaria seroprevalence rates: a cross-sectional analysis of malaria transmission in the Ouest and Sud-Est departments of Haiti
por: von Fricken, Michael E, et al.
Publicado: (2014) -
Investigations of socioeconomic factors associated with follow-up compliance with malaria treatment in Haiti
por: Carter, Tamar E., et al.
Publicado: (2021) -
Seroepidemiology of Burkholderia pseudomallei, Etiologic Agent of Melioidosis, in the Ouest and Sud-Est Departments of Haiti
por: Weppelmann, Thomas A., et al.
Publicado: (2018) -
High prevalence of asymptomatic malaria infections: a cross-sectional study in rural areas in six departments in Haiti
por: Elbadry, Maha A., et al.
Publicado: (2015)